A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac Disease

Recruiting

Phase 2

A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac DiseaseA Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac Disease

Sponsor:

Teva Branded Pharmaceutical Products R&D, Inc.

Code:

NCT06807463

Conditions

Celiac Disease

Eligibility Criteria

Sex: All

Age: 18 - 64

Healthy Volunteers: Not accepted

Interventions

TEV-53408

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by Teva Branded Pharmaceutical Products R&D, Inc. on 2025-03-25.